APA (7th ed.) Citation

Sertić, Z., Lucijanić, M., Bašić-Kinda, S., Seiwerth, R. S., Periša, V., Sertić, D., . . . Duraković, N. (2022). Non-Myelofibrosis Chronic Myeloproliferative Neoplasm Patients Show Better Seroconversion Rates after SARS-CoV-2 Vaccination Compared to Other Hematologic Diseases: A Multicentric Prospective Study of KroHem. MDPI AG.

Chicago Style (17th ed.) Citation

Sertić, Zrinka, et al. Non-Myelofibrosis Chronic Myeloproliferative Neoplasm Patients Show Better Seroconversion Rates After SARS-CoV-2 Vaccination Compared to Other Hematologic Diseases: A Multicentric Prospective Study of KroHem. MDPI AG, 2022.

MLA (9th ed.) Citation

Sertić, Zrinka, et al. Non-Myelofibrosis Chronic Myeloproliferative Neoplasm Patients Show Better Seroconversion Rates After SARS-CoV-2 Vaccination Compared to Other Hematologic Diseases: A Multicentric Prospective Study of KroHem. MDPI AG, 2022.